Mitchell Mcleod Pugh & Williams Inc. Sells 2,346 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Mitchell Mcleod Pugh & Williams Inc. decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 27.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,307 shares of the healthcare conglomerate’s stock after selling 2,346 shares during the period. UnitedHealth Group makes up 0.7% of Mitchell Mcleod Pugh & Williams Inc.’s holdings, making the stock its 29th biggest position. Mitchell Mcleod Pugh & Williams Inc.’s holdings in UnitedHealth Group were worth $3,191,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group in the third quarter valued at about $27,000. Global Wealth Strategies & Associates lifted its holdings in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares in the last quarter. West Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the third quarter valued at about $32,000. Quarry LP increased its position in shares of UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 37 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth about $37,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.1 %

Shares of NYSE:UNH opened at $510.03 on Tuesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a market cap of $469.37 billion, a PE ratio of 32.91, a P/E/G ratio of 1.39 and a beta of 0.62. The company’s 50 day moving average is $549.37 and its two-hundred day moving average is $563.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the firm posted $5.83 EPS. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. Equities analysts predict that UnitedHealth Group Incorporated will post 29.77 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.19%.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. Barclays cut their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday. Morgan Stanley reduced their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. KeyCorp reissued an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday. UBS Group reduced their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research note on Friday, January 10th. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.